Portfolio & Franchise Strategy

The Challenge

A pre-clinical biopharma company had developed a platform technology which identified a wide set of potential indications that spanned multiple therapeutic areas and disease states. The client asked Asymmetry to help build out a clear strategy and prioritization of potential therapeutic areas and indications to share with leadership and inform their clinical development pathways.

Asymmetry's Approach

1. Develop a systematic scoring matrix to assess and prioritize potential indications based on the science, the market opportunity, and the expected time / cost of development
2. Perform secondary research to apply the scoring matrix to potential indications across therapeutic areas
3. Based on insights from the research and prioritized indications, synthesize findings into a clear set of recommendations, priorities, and overall strategy
4. Facilitate alignment sessions with key client stakeholders in advance of presentation to the BOD

Our Impact

• Developed detailed assessment of 10+ indications across multiple therapeutic areas, with insights across the market opportunity, competitive landscape, potential MoD complexity

• Identified priority therapeutic areas and indications to move forward into pre-clinical and clinical development

• Aligned on strategy across key stakeholders in advance of presentation to the BoD